- Home
- TRUE vs VIGL Comparison
TRUE vs VIGL Comparison
Compare TRUE & VIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRUE
- VIGL
- Stock Information
- Founded
- TRUE 2005
- VIGL 2020
- Country
- TRUE United States
- VIGL United States
- Employees
- TRUE N/A
- VIGL N/A
- Industry
- TRUE Computer Software: Programming Data Processing
- VIGL Biotechnology: Pharmaceutical Preparations
- Sector
- TRUE Technology
- VIGL Health Care
- Exchange
- TRUE Nasdaq
- VIGL Nasdaq
- Market Cap
- TRUE 114.6M
- VIGL 134.9M
- IPO Year
- TRUE 2014
- VIGL 2022
- Fundamental
- Price
- TRUE $1.71
- VIGL $7.92
- Analyst Decision
- TRUE Buy
- VIGL Buy
- Analyst Count
- TRUE 5
- VIGL 7
- Target Price
- TRUE $3.19
- VIGL $8.00
- AVG Volume (30 Days)
- TRUE 265.8K
- VIGL 3.6M
- Earning Date
- TRUE 08-04-2025
- VIGL 08-12-2025
- Dividend Yield
- TRUE N/A
- VIGL N/A
- EPS Growth
- TRUE N/A
- VIGL N/A
- EPS
- TRUE N/A
- VIGL N/A
- Revenue
- TRUE $179,356,000.00
- VIGL N/A
- Revenue This Year
- TRUE $7.54
- VIGL N/A
- Revenue Next Year
- TRUE $11.02
- VIGL N/A
- P/E Ratio
- TRUE N/A
- VIGL N/A
- Revenue Growth
- TRUE 10.18
- VIGL N/A
- 52 Week Low
- TRUE $1.05
- VIGL $1.31
- 52 Week High
- TRUE $4.62
- VIGL $7.95
- Technical
- Relative Strength Index (RSI)
- TRUE 59.54
- VIGL 88.71
- Support Level
- TRUE $1.52
- VIGL $7.86
- Resistance Level
- TRUE $1.65
- VIGL $7.90
- Average True Range (ATR)
- TRUE 0.09
- VIGL 0.03
- MACD
- TRUE 0.02
- VIGL -0.18
- Stochastic Oscillator
- TRUE 91.30
- VIGL 80.00
About TRUE TrueCar Inc.
TrueCar Inc is a data-driven online platform operating on common technology infrastructure, powered by proprietary data and analytics. It also customizes and operates its platform for affinity group marketing partners, including financial institutions like PenFed and American Express; membership-based organizations like Consumer Reports, AARP, Sam's Club, and AAA; and employee buying programs for large enterprises such as IBM and Walmart. The Company has one operating segment, with three distinct service offerings: Dealer products and services, OEM incentives, and other.
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.